Health

New Generation of Therapies Targets ‘Cold’ Solid Tumors

New Generation of Therapies Targets ‘Cold’ Solid Tumors

A surge in innovation and clinical trials is transforming the treatment of 'cold' solid tumors. From new NK cell engagers like GTB-5550 to cutting-edge HLA-independent T-cell research, oncology is rapidly addressing long-standing immunotherapy resistance.